GWW vs TARS · P/E 27, rev $9.76B vs rev $336.0M
WW Grainger Inc (GWW) versus Tarsus Pharmaceuticals Inc (TARS) — a side-by-side from cached financials, not a winner call.
WW Grainger Inc (GWW) is a industrial distribution company listed on US.
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
Latest reported GWW revenue for 2026-06-30 was $9.76B. Net income was $1.13B. GWW currently screens at market cap $50.34B and trailing P/E 26.9.
Latest reported TARS revenue for 2026-06-30 was $336.0M. Net income was -$25.5M. TARS currently screens at market cap $2.66B.
GWW currently screens at market cap $50.34B and trailing P/E 26.9. TARS currently screens at market cap $2.66B.
Not investment advice. Open the GWW and TARS stock pages for the full models.
Not investment advice.